On Friday, October 24, 2024, President Joe Biden formally apologized to the indigenous peoples of North America for the abuses committed against thousands ...
Global Central Nervous System Therapeutics Market is valued at approximately USD 143.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period ...
Opdivo® (nivolumab) is now funded in New Zealand for eligible patients with metastatic clear cell renal cell carcinoma (RCC) (advanced kidney cancer) after prior anti-angiogenic therapy.1 OPDIVO ...